With the emergence and long-term Impact of COVID-19, Global Vitamin D Therapy Market to reach USD 11.04 billion by 2030
Bizwit Research & Consulting LLP’s recent analysis on the Global Vitamin D Therapy Market points towards a potential rise to USD 11.04 billion by 2030. Vitamin D therapy involves to the usage of vitamin D supplements or therapeutic methods to mitigate deficits or oversee health issues related to insufficient amounts of vitamin D. It aims to restore optimal vitamin D levels crucial for bone health, immune function, and overall well-being. Administered through oral supplements, injections, or other forms, vitamin D therapy is prescribed based on individual needs and medical history, often guided by laboratory tests. It is beneficial for populations with limited sun exposure, dietary deficiencies, malabsorption issues, or certain medical conditions.
The therapy helps prevent or manage conditions such as osteoporosis, rickets, autoimmune disorders and cardiovascular diseases. Healthcare professionals oversee vitamin D therapy to ensure safe and effective outcomes, emphasizing proper dosage and monitoring to avoid toxicity. The increase in awareness campaigns and initiatives about vitamin D deficiency by the government and manufacturers, rise in incidences of the chronic diseases, and rising consumer preference for preventive healthcare are the most prominent factors that are propelling the market demand across the globe.
Geographically, the global Vitamin D Therapy market has been segmented into North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA). North America dominated the market in 2022 owing to the growing awareness of vitamin D deficiency, extensive research to develop more patient-friendly products with improved efficacy and the rise in healthcare spending.
Also, the decreased physical activity, obesity, and lower social status are associated with low vitamin D levels. For instance, a CDC report from January 2022 revealed that 25% of American adults do not engage in sufficient physical activity for maintaining health. Physical inactivity rates vary across states and territories, ranging from 17.7% in Colorado to 49.4% in Puerto Rico. This decline in physical activity heightens the risk of vitamin D deficiency among individuals, potentially fueling the demand for treatment and bolstering market expansion.
Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The growing awareness regarding vitamin D deficiency and bolstered by supportive government initiatives aimed at implementing treatment plans for addressing vitamin D deficiency are significantly propelling the market demand across the region. Additionally, factors such as significant air pollution levels, sedentary lifestyles, escalating incidence of vitamin D deficiency, unconventional dietary habits, reduced sun exposure, and rising malnutrition levels contribute to the increasing demand for vitamin D deficiency treatment in the region.
The global Vitamin D Therapy market is highly competitive owing to the presence of several key players such as Abbott Laboratories (US) Sanofi SE (France) GlaxoSmithKline plc (UK) Pfizer Inc. (US) Merck & Co., Inc. (US) Torrent Pharmaceuticals Ltd. (India) Novartis International AG (Switzerland) Alkem Laboratories (India) Sun Pharmaceutical Industries Ltd. (India) Cadila Healthcare Ltd (India) and others.
For further analysis on this or to request a sample copy of this report, please click the link mentioned below:
Key findings of the study suggest:
- Global Vitamin D Therapy Market is anticipated to grow with a healthy growth rate of more than 11.6% over the forecast period 2023-2030.
- In the Route of Administration segment, Oral Route emerged out as the leading market segment in 2022.
- North America is anticipated to drive regional growth owing to rise in healthcare spending in the region.
- Asia Pacific is expected to grow at higher rate owing to rising supportive government initiatives aimed at implementing treatment plans for addressing vitamin D deficiency in the region.
Bizwit Research & Consulting has considered following segments for the study:
By Route of Administration:
- Oral Route
- Parenteral Route
By Purchasing Pattern:
- OTC Drugs
- Prescription Drugs
By Application:
- Osteoporosis
- Rickets
- Skin Diseases
- Muscle Weakness
- Autoimmune Disorders
- Other Applications
By Age Group:
- Children
- Adults
- Senior Adults
Regional Outlook
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Korea
- Australia
- RoAPAC
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
To get a sample of this report or to purchase a copy of the study, you can directly contact us at: sales@bizwitresearch.com
About Us
Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. The company has a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. Bizwit incorporate big data, expert analysis, and huge industry database to deliver client focused business consulting reports. Our analysts perform unbiased measurement and assessment of market opportunities to comprehend detailed market forecast. Our team of key opinion leaders evaluates the market size, growth prospects, end-use, applications, value & supply chain and top vendors in the industry to help the clients to take conversant business decisions without any vague assumptions.
Contact US
Global Business Development
Phone: +1 209 498-3066
Email: Sales@bizwitresearch.com
Website: www.bizwitresearch.com
